A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
NCT02921828
·
clinicaltrials.gov ↗
COMPLETED
Status
1149
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Sponsor
Celgene